Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Hatami

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Scientific Reports|February 14, 2024
Dietary acid load and cirrhosis-related mortality: a prospective cohort studyFereshteh Pashayee-Khamene, Zeinab Heidari, Danial Fotros, et al.
European Journal of Clinical Nutrition|January 21, 2022
Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trialBanafshe Khodami, Behzad Hatami, Zahra Yari, et al.
BMC Gastroenterology|November 7, 2024
The association between plant-based diet indices and risk of mortality in patients with cirrhosis: a cohort studyMohsen Shaygan Tabar, Danial Fotros, Azita Hekmatdoost, et al.
Cell Biology International|January 19, 2023
Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124Helia Alavifard, Sogol Mazhari, Anna Meyfour, et al.
Case Reports in Gastroenterology|May 29, 2018
Epinephrine in the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Preliminary StudyBehzad Hatami, Seyed Mohammad Hossein Kashfi, Mohammad Abbasinazari, et al.
Journal of Diabetes and Metabolic Disorders|June 8, 2022
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adultsEhsaneh Taheri, Mohammad Amin Pourhoseingholi, Alireza Moslem, et al.
The Journal of Nutrition|November 18, 2021
Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control StudyEhsaneh Taheri, Roberd M Bostick, Behzad Hatami, et al.
European Journal of Gastroenterology & Hepatology|November 17, 2016
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitisAmir H Mohammad Alizadeh, Mohammad Abbasinazari, Behzad Hatami, et al.
Scientific Reports|February 8, 2025
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort studyMohsen Shaygan Tabar, Maryam Nilghaz, Azita Hekmatdoost, et al.
Scientific Reports|March 1, 2024
The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin AAsal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Scientific Reports|February 14, 2024
Dietary acid load and cirrhosis-related mortality: a prospective cohort studyFereshteh Pashayee-Khamene, Zeinab Heidari, Danial Fotros, et al.
European Journal of Clinical Nutrition|January 21, 2022
Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trialBanafshe Khodami, Behzad Hatami, Zahra Yari, et al.
BMC Gastroenterology|November 7, 2024
The association between plant-based diet indices and risk of mortality in patients with cirrhosis: a cohort studyMohsen Shaygan Tabar, Danial Fotros, Azita Hekmatdoost, et al.
Cell Biology International|January 19, 2023
Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL-6 pathway through miR-124Helia Alavifard, Sogol Mazhari, Anna Meyfour, et al.
Case Reports in Gastroenterology|May 29, 2018
Epinephrine in the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Preliminary StudyBehzad Hatami, Seyed Mohammad Hossein Kashfi, Mohammad Abbasinazari, et al.
Journal of Diabetes and Metabolic Disorders|June 8, 2022
The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adultsEhsaneh Taheri, Mohammad Amin Pourhoseingholi, Alireza Moslem, et al.
The Journal of Nutrition|November 18, 2021
Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control StudyEhsaneh Taheri, Roberd M Bostick, Behzad Hatami, et al.
European Journal of Gastroenterology & Hepatology|November 17, 2016
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitisAmir H Mohammad Alizadeh, Mohammad Abbasinazari, Behzad Hatami, et al.
Scientific Reports|February 8, 2025
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort studyMohsen Shaygan Tabar, Maryam Nilghaz, Azita Hekmatdoost, et al.
Scientific Reports|March 1, 2024
The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin AAsal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, et al.
Pageof 9